Moore Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,800
| Closed | -$13.5M | – | 481 |
|
|
2024
Q2 | $13.5M | Sell |
12,800
-4,200
| -25% | -$4.41M | 0.23% | 95 |
|
|
2024
Q1 | $16.4M | Buy |
17,000
+6,000
| +55% | +$5.77M | 0.26% | 73 |
|
|
2023
Q4 | $9.66M | Buy |
+11,000
| New | +$9.66M | 0.17% | 82 |
|
|
2023
Q2 | – | Sell |
-10,000
| Closed | -$8.22M | – | 540 |
|
|
2023
Q1 | $8.22M | Buy |
+10,000
| New | +$8.22M | 0.17% | 89 |
|
|
2022
Q4 | – | Sell |
-41,991
| Closed | -$28.9M | – | 610 |
|
|
2022
Q3 | $28.9M | Buy |
41,991
+18,264
| +77% | +$12.6M | 0.68% | 20 |
|
|
2022
Q2 | $14M | Buy |
23,727
+6,521
| +38% | +$3.85M | 0.37% | 40 |
|
|
2022
Q1 | $12M | Buy |
+17,206
| New | +$12M | 0.31% | 53 |
|
|
2021
Q3 | – | Sell |
-42,640
| Closed | -$23.8M | – | 840 |
|
|
2021
Q2 | $23.8M | Buy |
+42,640
| New | +$23.8M | 0.34% | 55 |
|
|
2021
Q1 | – | Sell |
-22,804
| Closed | -$11M | – | 745 |
|
|
2020
Q4 | $11M | Buy |
+22,804
| New | +$11M | 0.12% | 107 |
|